The Role of Botanicals in Microbial Balance and Systemic Health

What if you could catch gut dysbiosis or increase microbial diversity before LPS became systemic and caused severe symptoms? Recent research supports the role botanicals play in producing short-chain fatty acids (SCFAs) and the modulation of gut microbiota composition, proving valuable tools to support patients with whole-body health.

 

Read more

Systemic Disease and the LPS Connection

Now that we are aware of the microbiome, and its relationship to systemic inflammatory conditions, it becomes clear that regular evaluation of the microbiome is essential to achieve and maintain lasting therapeutic effects for our patients.

 

Read more

The Microbiome: Short-Chain Fatty Acids and the LPS Connection

Do you wonder about the role that microbes play when you see conditions related to inflammation? In this series, Kristen Klos-Maki, DC, dives into the science that explains how overgrowth of harmful bacteria generates inflammation, and why inflammatory issues improve when we address microbiome and gut health.

 

Read more

Chronic Lyme Part 3: Treatment Considerations

Emily Hernandez, ND, a Lyme specialist with significant clinical experience, shares essential steps to support even the most sensitive and complex patients, simplifying and clarifying possible treatment strategies.

 

Read more

Chronic Lyme Part 2: Testing and Diagnosis

Lyme is known as “The Great Imitator” because of its variety and complexity. Emily Hernandez, ND, a Lyme specialist, brings clarity to testing options to help practitioners identify when Lyme and its coinfections are the root cause of illness.

 

Read more

A Conversation about Clostridia

Listen in as Jocelyn Strand, ND, Biocidin’s Director of Clinical Education, and Functional and Integrative Medicine expert Kurt Woeller, DO, discuss treatment strategies and effective protocols for using the Biocidin line of products with Clostridia species concerns.

 

Read more

Clostridia Bacterial Concerns Part 3: Intervention Options

Once you've identified C. diff as the problem, what are the clinically effective therapeutics for addressing it? Longtime practitioner Kurt Woeller, DO, discusses conventional and alternative treatment methods and weighs the benefits and risks of each.

<script src="https://fast.wistia.com/embed/medias/d310gn306i.jsonp" async></script><script src="https://fast.wistia.com/assets/exter...

Read more

Clostridia Bacterial Concerns Part 2: Laboratory Testing Options

Do you see symptoms in your patients that make you suspect Clostridium difficile (C. diff)? What's the best way to confirm your suspicions? Kurt Woeller, DO, identifies the methods he finds most effective for detecting C. diff in patients, including both conventionally accepted as well as alternative techniques.

 

Read more

Clostridia Bacterial Concerns Part 1: Pathogenicity Mechanisms

Clostridium difficile is labeled as one of the organisms of greatest concern for antibiotic resistance by the National Institutes of Health. It can also colonize the gastrointestinal tract, creating chronic symptoms that are harder to recognize. In this first installment of a three-part series, Kurt Woeller, DO discusses the breadth of symptoms that can manifest with Clostridium difficile and other pathogenic species.

<script src="https://fast.wistia.com/embed/medias/j97wvgesrj.jsonp" async></script><script src="https://fast.wistia.com/assets/exter...

Read more

Candidiasis Part 1–3

Gastrointestinal candidiasis (GC) is well-known to functional and integrative medicine providers. In this article, Kurt Woeller, DO, discusses various aspects of chronic candidiasis as it relates to different health conditions and explores different mechanisms of pathogenicity including arabinose toxicity, leaky gut (intestinal permeability), invasive protein, and immune deficiency.

 

Read more

Candidiasis Part 3: Treatment Options

Recordings/Articles.pdf to be edited Recordings/Articles.pdf to be edited 100% 10 H21 Invasive Candida. What can be done about it? Kurt Woeller, DO, discusses three distinct categories of intervention: systemic, non-systemic, and botanical. He specifically explores two antifungal medications and five botanicals known to be helpful in addressing chronic candidiasis. Screen reader support enabled. Invasive Candida. What can be done about it? Kurt Woeller, DO, discusses three distinct categories of intervention: systemic, non-systemic, and botanical. He specifically explores two antifungal medications and five botanicals known to be helpful in addressing chronic candidiasis. Turn on screen reader support

 

Read more